| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |